Authors
Latest:
Three Challenges in Medication Adherence That Can Be Overcome by PharmacistsMedication nonadherence results in greater health care spending and poorer patient health outcomes.
Latest:
University Partnerships: Empowering the Next Generation of PharmacistsCorporate and academic partnerships help prepare new graduates for the world of specialty pharmacy.
Latest:
Combining a Passion for Making a Difference With EntrepreneurshipDirections in Oncology Pharmacy® talks to Gordon Vanscoy, PharmD, MBA, CACP, recently named a national Entrepreneur of the Year for 2020 by Ernst & Young.
Latest:
Penicillin Allergies and Cross-Reactivity With Other Beta-LactamsPatient-reported allergy to penicillin antibiotics is a common scenario during health care encounters, with an estimated population prevalence of roughly 8% to 12%.
Latest:
Pharmacists Can Play Key Role in Drug RepurposingPharmacists should be aware of what drug repurposing is and how it occurs as due to the vast amount of opportunities that exist.
Latest:
Economic Burden of Atrial Fibrillation: Implications for InterventionBecause the increasing prevalence of atrial fibrillation imposes significant financial and clinical burdens, efficient healthcare delivery is required to improve outcomes and reduce associated costs.
Latest:
Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid ArthritisFor patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.
Latest:
Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving ChemotherapyFor US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.
Latest:
Does Your Controlled Substance Compliance Program Adequately Address Pharmacists’ Corresponding Responsibility?Pharmacists struggling to reconcile their duty to dispense with legal obligations to prevent drug diversion must exercise judgment when determining whether a prescription is suspect or legitimate.Â
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
Help Patients Manage Cold and Flu SymptomsConsider patients' disease states, medication regimens, and other regularly used nonprescription drugs.
Latest:
Lisocabtagene Maraleucel: A Review of IndicationsLisocabtagene maraleucel chimeric antigen receptor T-cell therapy significantly enhances treatment of relapsed/refractory B-cell malignancies, offering high response rates and durable remissions.
Latest:
Ask Questions, Get Feedback to Make the Most of APPE RotationsTo maximize this challenging experience, pharmacy students should be eager to learn and inquisitive.
Latest:
Improve the Pharmaceutical Ecosystem for PatientsHealth care policy decisions based on sound data and research are essential for addressing the challenges.
Latest:
How to Support Patients and Ensure Adherence to Specialty TherapiesAlthough specialty therapies have the potential to help people live healthier lives, their cost and complexity can create distinct challenges.
Latest:
The Evolving Pharmacist Role in HER2-Negative Adjuvant Breast Cancer TherapyJulia Ziegengeist, PharmD, BCOP offers insights for pharmacists navigating adjuvant and neoadjuvant treatment of breast cancer.
Latest:
Five Trends Transforming Pharmacies into Wellness Centers of the FutureWith so many radical developments in medicine and technology unfolding at once, the role and potential of the pharmacy as we know it is evolving at breakneck speed.
Latest:
AUC 5 vs AUC 6: MUSC Study Highlights the Tradeoffs in Neoadjuvant Breast Cancer TreatmentLacy La Fever, PharmD, MS, discussed outcomes associated with different carboplatin AUC dosing strategies.
Latest:
Medically Integrated Pharmacies: The Role of Limited Distribution Networks in Advancing Modern Oncology PharmacyJonas Congelli, RPh, discusses how limited distribution networks and medically integrated pharmacies can improve access, continuity, and quality of oncology care—particularly in underserved areas—while addressing systemic barriers posed by traditional distribution models and pharmacy benefit managers.
Latest:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapeThis review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Latest:
Review of 3 Alternative Pathways to Access Non–FDA-Approved DrugsNon–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Latest:
Asembia AXS25: Leveraging Advanced Analytics and Data Insights to Improve Specialty Pharmacy Patient OutcomesSpecialty pharmacies can leverage advanced analytics, AI, and comprehensive data insights to create targeted clinical programs.
Latest:
Pharmacist Workload Expected to Increase Again This Fall: How Technology Can HelpThere is a real opportunity for technology to alleviate some of the administrative burdens pharmacists face so that they have more time to focus on patient care.
